Izotropic Corporation announced it is bringing its medical device engineering and product development to its in-house facility located in Sacramento, CA. The move comes at a critical time as the company is building devices for its future clinical studies for market authorization in the U.S. and elsewhere. As the company transitions from a virtual to an in-person working environment, it is taking advantage of the opportunity to position itself closer to the highly specialized resources required to successfully commercialize IzoView and future breast CT products in the U.S. market.

To date, the development of IzoView and the contributing resources required have been shifting to the company's dedicated engineering consultants in the U.S. from the foundational work completed with Starfish Medical, a contract medical device engineering firm located in British Columbia, Canada. By transitioning this activity to the U.S., the company expects to yield the following benefits: Increasing productivity through the unrestricted access of IzoView and the proximity to the company's key medical and technical resources; Closer proximity to U.S. suppliers, production, manufacturers, and customers; Development and engineering efficiency by mitigating cross border supply chain and travel risks; Smoother transition and acceleration of future breast CT products across the IzoView Platform.